ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 172 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,593,000 | -14.8% | 26,950 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $1,870,000 | +3.6% | 26,950 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $1,805,000 | -13.6% | 26,950 | 0.0% | 0.01% | -25.0% |
| Q4 2020 | $2,089,000 | -8.1% | 26,950 | -11.1% | 0.01% | -20.0% |
| Q3 2020 | $2,274,000 | -40.9% | 30,300 | -54.4% | 0.01% | -47.4% |
| Q2 2019 | $3,846,000 | +143.7% | 66,400 | +63.5% | 0.02% | +111.1% |
| Q1 2019 | $1,578,000 | +23.5% | 40,600 | +22.3% | 0.01% | +12.5% |
| Q4 2018 | $1,278,000 | -19.0% | 33,200 | -18.2% | 0.01% | -11.1% |
| Q3 2018 | $1,578,000 | -10.5% | 40,600 | -2.6% | 0.01% | -18.2% |
| Q2 2018 | $1,764,000 | +166.9% | 41,700 | +149.7% | 0.01% | +120.0% |
| Q1 2018 | $661,000 | – | 16,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |